BRIANNA BARTON: Open Payments
NPI 1366112278 · SOUTHINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,124 in 43 payments from 12 companies in 2025. Trend: 2023 $114 · 2024 $128 · 2025 $1,124
Food & beverage: $1,124
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $437 |
| TG Therapeutics, Inc. | 3 | $208 |
| Novartis Pharmaceuticals Corporation | 2 | $129 |
| Genentech USA, Inc. | 4 | $83 |
| PFIZER INC. | 2 | $44 |
| UCB, Inc. | 2 | $40 |
| Celgene Corporation | 2 | $38 |
| Neurelis, Inc. | 1 | $37 |
| ARGENX US, INC. | 1 | $33 |
| Mallinckrodt Hospital Products Inc. | 1 | $33 |
Products named: UBRELVY, BRIUMVI, QULIPTA, KESIMPTA, BOTOX, NURTEC ODT, Ocrevus Zunovo, Ocrevus.
Industry payments across CT — which companies pay providers there.
